Capstone Investment Advisors, LLC Incyte Corp Transaction History

Capstone Investment Advisors, LLC

  • $24.9 Billion
  • Q1 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 200 shares of INCY stock, worth $11,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 1,008 80.16%
Holding current value
$11,466
Previous $63,000 82.54%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024
BUY
$56.55 - $66.59 $809,230 - $952,902
14,310 Added 1419.64%
15,318 $872,000
Q4 2023

Feb 12, 2024
SELL
$52.16 - $64.19 $564,788 - $695,049
-10,828 Reduced 91.48%
1,008 $63,000
Q3 2023

Nov 13, 2023
SELL
$57.77 - $65.93 $24,552 - $28,020
-425 Reduced 3.47%
11,836 $683,000
Q2 2023

Aug 10, 2023
BUY
$60.95 - $75.51 $386,118 - $478,355
6,335 Added 106.9%
12,261 $763,000
Q1 2023

May 09, 2023
BUY
$70.23 - $86.01 $416,182 - $509,695
5,926 New
5,926 $428,000
Q3 2022

Nov 10, 2022
BUY
$66.18 - $82.86 $326,532 - $408,831
4,934 Added 539.23%
5,849 $390,000
Q2 2022

Aug 15, 2022
BUY
$66.18 - $83.18 $60,223 - $75,693
910 Added 18200.0%
915 $70,000
Q1 2022

May 13, 2022
SELL
$66.02 - $79.71 $3.39 Million - $4.1 Million
-51,378 Reduced 99.99%
5 $0
Q4 2021

Feb 11, 2022
SELL
$63.34 - $74.11 $890,117 - $1.04 Million
-14,053 Reduced 21.48%
51,383 $3.77 Million
Q3 2021

Nov 15, 2021
BUY
$68.67 - $84.02 $3.38 Million - $4.14 Million
49,240 Added 304.03%
65,436 $0
Q2 2021

Aug 16, 2021
SELL
$79.87 - $87.53 $741,113 - $812,190
-9,279 Reduced 36.42%
16,196 $0
Q1 2021

May 17, 2021
BUY
$76.02 - $100.5 $716,716 - $947,514
9,428 Added 58.75%
25,475 $2.07 Million
Q4 2020

Feb 16, 2021
BUY
$80.74 - $97.7 $1.15 Million - $1.39 Million
14,261 Added 798.49%
16,047 $1.4 Million
Q3 2020

Nov 16, 2020
BUY
$85.07 - $109.69 $99,531 - $128,337
1,170 Added 189.94%
1,786 $160,000
Q3 2019

Nov 14, 2019
SELL
$72.82 - $86.52 $58,328 - $69,302
-801 Reduced 56.53%
616 $46,000
Q2 2019

Aug 14, 2019
SELL
$73.52 - $88.7 $13,674 - $16,498
-186 Reduced 11.6%
1,417 $120,000
Q4 2018

Feb 14, 2019
SELL
$58.5 - $69.94 $74,353 - $88,893
-1,271 Reduced 44.22%
1,603 $102,000
Q3 2018

Nov 14, 2018
BUY
$61.75 - $74.23 $177,469 - $213,337
2,874 New
2,874 $199,000
Q1 2018

May 15, 2018
SELL
$83.06 - $100.98 $224,262 - $272,646
-2,700 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$93.56 - $116.6 $196,476 - $244,860
-2,100 Reduced 43.75%
2,700 $255,000
Q3 2017

Nov 14, 2017
BUY
$109.15 - $138.27 $523,920 - $663,696
4,800
4,800 $560,000

Others Institutions Holding INCY

# of Institutions
618
Shares Held
215M
Call Options Held
366K
Put Options Held
445K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email